Prospera Financial Services Inc Puma Biotechnology, Inc. Transaction History

Prospera Financial Services Inc

$3.82 Billion
Q3 2024

A detailed history of Prospera Financial Services Inc transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Prospera Financial Services Inc holds 168,885 shares of PBYI stock, worth $559,009. This represents 0.01% of its overall portfolio holdings.

Number of Shares

168,885

Previous 149,570 12.91%

Holding current value

$559,009

Previous $487,000 11.7%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$2.25 - $4.03 $43,458 - $77,839	19,315 Added 12.91%	168,885 $430,000
Q2 2024 Aug 13, 2024	BUY	$2.92 - $5.83 $18,550 - $37,037	6,353 Added 4.44%	149,570 $487,000
Q1 2024 Aug 13, 2024	SELL	$4.29 - $7.4 $7,627 - $13,157	-1,778 Reduced 1.19%	147,792 $783,000
Q4 2023 Feb 14, 2024	BUY	$2.23 - $4.49 $45,324 - $91,259	20,325 Added 16.54%	143,217 $620,000
Q3 2023 Nov 13, 2023	BUY	$2.63 - $4.09 $37,987 - $59,075	14,444 Added 13.32%	122,892 $323,000
Q2 2023 Aug 08, 2023	BUY	$2.6 - $3.58 $21,777 - $29,986	8,376 Added 8.37%	108,448 $382,000
Q1 2023 May 12, 2023	BUY	$2.21 - $4.82 $25,967 - $56,635	11,750 Added 13.3%	100,072 $309,000
Q4 2022 Feb 08, 2023	BUY	$2.12 - $5.08 $12,879 - $30,861	6,075 Added 7.39%	88,322 $373,000
Q3 2022 Oct 27, 2022	BUY	$2.27 - $3.84 $20,028 - $33,880	8,823 Added 12.02%	82,247 $195,000
Q2 2022 Aug 08, 2022	BUY	$1.64 - $3.3 $22,540 - $45,355	13,744 Added 23.03%	73,424 $209,000
Q1 2022 May 04, 2022	BUY	$2.13 - $3.24 $50,370 - $76,619	23,648 Added 65.63%	59,680 $172,000
Q4 2021 Feb 10, 2022	BUY	$2.85 - $6.58 $1,915 - $4,421	672 Added 1.9%	36,032 $110,000
Q3 2021 Nov 12, 2021	BUY	$6.63 - $9.39 $63,747 - $90,284	9,615 Added 37.35%	35,360 $248,000
Q2 2021 Aug 12, 2021	BUY	$8.98 - $11.6 $35,713 - $46,133	3,977 Added 18.27%	25,745 $236,000
Q1 2021 May 06, 2021	BUY	$9.38 - $13.63 $27,577 - $40,072	2,940 Added 15.62%	21,768 $212,000
Q4 2020 Feb 12, 2021	BUY	$7.78 - $12.13 $146,481 - $228,383	18,828 New	18,828 $193,000
Q3 2020 Nov 04, 2020	SELL	$9.5 - $11.14 $115,767 - $135,752	-12,186 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$7.01 - $13.24 $85,423 - $161,342	12,186 New	12,186 $127,000

Others Institutions Holding PBYI

# of Institutions

101

Shares Held

29M

Call Options Held

50.6K

Put Options Held

16.3K

View Full List

About PUMA BIOTECHNOLOGY, INC.

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $151M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

More about PBYI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prospera Financial Services Inc with notifications on news.

Account

Prospera Financial Services Inc Puma Biotechnology, Inc. Transaction History